Pall Biotech | Vaccine Production: Securing process quality with flexible manufacturing solutions for all vaccine platforms
From the first inspiration in the late 18th century to gene-based DNA and RNA vaccines and novel cancer immunotherapies vaccines teach the body’s natural defences to target unwanted bacterial, viral and cellular threats. The antigens that have been used to form the foundation of this instruction include whole bacteria or virus, and sub-units such as polysaccharides or proteins, and these may be conjugated to additional proteins or combined with other adjuvants to enhance the immune response. This diversity in the type of vaccine antigen, along with the inherent variation in the targets, have created challenges for vaccine manufacturers….. Learn More
Available to Stream: 2020 Sessions
Watch the 2020 INTERPHEX Live Sessions via YouTube! Video preview:
Update on What’s New with the FDA & Inspections
Pharma Intelligence: 2020 State of Investment
Recap: Technologies Tours Week
Stream the IPS and INTERPHEX Technologies Tours on our
Stay Tuned! 2021 Registration is opening soon along with the launch of our new and improved website! Check your inbox and our site next week to learn more.
